WHO to review Merck’s ebola vaccine for emergency use
Worldwide drug manufacturer Merck recently announced that its application for Emergency Use Assessment and Listing (EUAL) for the company’s Ebola Zaire vaccine (V920) has been accepted for review by the World Health Organization. The EUAL is designed specifically to expedite … Read More